Translate page

Collage Bhatia MustjokiTopic: CML Biology related to TFR

Date: September 22nd at 14.30 Central European Summer Time

Join our two experts as they discuss key aspects of the biology of CML
specifically related to TFR:

  • Leukemic stem cells and microenvironmental regulation:
    Professor Ravi Bhatia, Director of the University of Alabama Division of Hematology/Oncology and Deputy Director of the O’Neal Comprehensive Cancer Center, University of Alabama
    (Birmingham, USA)
  • Immunology of CML:
    Professor Satu Mustjoki, Principal Investigator and Group Leader at the Hematology Research Unit Helsinki, Professor of Translational Hematology at the University of Helsinki and Research Professor at the Finnish Cancer Institute (Helsinki, Finland)

CD5038 Conversations tile 27x128 

The iCMLf is hosting monthly 'iCMLf Conversations on CML' with expert live discussions on various topics in CML management. On this page you will find recordings from past conversations with renowned CML experts that cover a wide range of topics like;

  • CML and pregnancy
  • CML highlights of EHA 2021
  • CML and COVID-19: What do we know so far?
  • Treatment-free remission in children with CML
  • COVID-19 vaccines and CML
  • Virtual iCMLf Forum: Meet-the-expert Session
  • CML highlights from ASH 2020
  • Treatment-free remission
  • Current research in CML
  • 2020 ELN recommendations

Watch out for more expert discussions in the next couple of weeks.

  Abruzzese Chelysheva

Panel of experts:

Dr Elisabetta Abruzzese
Associate Professor, S Eugenio Hospital, Tor Vergata University, Rome (Italy)

Dr Ekaterina Chelysheva
Senior Researcher, National Research Center for Hematology, Moscow (Russian Federation)

 

Collage Hehlmann Pagani

Panel of experts:

Professor Rüdiger Hehlmann
Founder and coordinator European LeukemiaNet / Founder and chair ELN Foundation and former Chief of Medicine at the Mannheim Medical Faculty, University of Heidelberg (Germany)

Dr Ilaria Pagani
Dr Ilaria Pagani, Affiliate Senior Lecturer University of Adelaide/SAHMRI (Australia)

Mauro Naranie

Panel of experts:

Professor Michael Mauro
Memorial Sloan Kettering Cancer Center and Weill Cornell Medicine,
New York (USA)

Dr Naranie Shanmuganathan
Royal Hospital and SA Pathology,
Adelaide (Australia)